Estrella Immunopharma Statistics
Total Valuation
ESLA has a market cap or net worth of $75.15 million. The enterprise value is $73.53 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ESLA has 37.77 million shares outstanding. The number of shares has increased by 2.36% in one year.
| Current Share Class | 37.77M |
| Shares Outstanding | 37.77M |
| Shares Change (YoY) | +2.36% |
| Shares Change (QoQ) | +2.57% |
| Owned by Insiders (%) | 2.12% |
| Owned by Institutions (%) | 1.97% |
| Float | 11.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.15
| Current Ratio | 0.15 |
| Quick Ratio | 0.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 137.32% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -636 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +65.83% in the last 52 weeks. The beta is 0.53, so ESLA's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | +65.83% |
| 50-Day Moving Average | 1.92 |
| 200-Day Moving Average | 1.21 |
| Relative Strength Index (RSI) | 50.96 |
| Average Volume (20 Days) | 243,266 |
Short Selling Information
The latest short interest is 170,374, so 0.45% of the outstanding shares have been sold short.
| Short Interest | 170,374 |
| Short Previous Month | 63,002 |
| Short % of Shares Out | 0.45% |
| Short % of Float | 1.46% |
| Short Ratio (days to cover) | 0.17 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.51M |
| Pretax Income | -13.51M |
| Net Income | -13.51M |
| EBITDA | n/a |
| EBIT | -13.51M |
| Earnings Per Share (EPS) | -$0.37 |
Full Income StatementBalance Sheet
The company has $1.63 million in cash and $4,000 in debt, giving a net cash position of $1.62 million or $0.04 per share.
| Cash & Cash Equivalents | 1.63M |
| Total Debt | 4,000 |
| Net Cash | 1.62M |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | -9.84M |
| Book Value Per Share | -0.26 |
| Working Capital | -11.34M |
Full Balance SheetCash Flow
| Operating Cash Flow | -1.09M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |